Orchid Pharma Limited - Penyata Pendapatan (TTM)

Orchid Pharma Limited
IN ˙ NSEI
Penyata Pendapatan (TTM)

Orchid Pharma Limited Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 4,687 4,420 4,501 4,232 4,424 5,010 5,596 5,982 6,357 6,341 6,659 7,178 7,513 8,122 8,194 8,809 9,048 9,015 9,219 8,504
Perubahan (%) -5.69 1.82 -5.97 4.53 13.24 11.69 6.91 6.27 -0.25 5.01 7.80 4.67 8.10 0.89 7.50 2.72 -0.36 2.26 -7.75
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 2,122 2,197 2,413 2,380 2,699 3,027 3,271 3,491 3,781 3,813 4,013 4,435 4,655 4,919 5,032 5,414 5,502 5,531 5,672 4,928
Perubahan (%) 3.57 9.81 -1.36 13.37 12.16 8.07 6.72 8.31 0.84 5.24 10.53 4.96 5.66 2.30 7.59 1.63 0.52 2.55 -13.11
% daripada Hasil 45.27 49.71 53.62 56.24 61.00 60.41 58.46 58.35 59.47 60.12 60.26 61.79 61.96 60.56 61.41 61.46 60.81 61.34 61.52 57.95
Keuntungan Operasi Kasar 2,565 2,223 2,088 1,852 1,725 1,983 2,325 2,492 2,577 2,529 2,646 2,743 2,858 3,203 3,162 3,395 3,546 3,485 3,548 3,576
Perubahan (%) -13.35 -6.08 -11.29 -6.83 14.95 17.22 7.18 3.41 -1.86 4.66 3.65 4.19 12.07 -1.28 7.37 4.45 -1.72 1.80 0.80
% daripada Hasil 54.73 50.29 46.38 43.76 39.00 39.59 41.54 41.65 40.53 39.88 39.74 38.21 38.04 39.44 38.59 38.54 39.19 38.66 38.48 42.05
SG&A 800 882 686 655 623 606 649 643 654 646 664 680 678 703 730 788 813 842 882 860
Perubahan (%) 10.21 -22.22 -4.56 -4.85 -2.72 7.00 -0.85 1.77 -1.37 2.81 2.47 -0.25 3.63 3.82 7.92 3.18 3.58 4.82 -2.57
% daripada Hasil 17.08 19.96 15.25 15.47 14.08 12.10 11.59 10.75 10.29 10.18 9.97 9.47 9.03 8.66 8.91 8.94 8.98 9.34 9.57 10.11
R&D
Perubahan (%)
% daripada Hasil
OpEx 5,758 5,393 5,006 4,821 4,999 5,307 5,934 6,210 6,495 6,362 6,369 6,652 6,833 7,235 7,417 7,936 8,113 8,164 8,390 7,863
Perubahan (%) -6.34 -7.19 -3.68 3.69 6.16 11.82 4.63 4.59 -2.04 0.11 4.45 2.72 5.88 2.52 6.99 2.23 0.63 2.76 -6.27
% daripada Hasil 122.86 122.01 111.22 113.92 113.00 105.94 106.06 103.80 102.16 100.33 95.65 92.67 90.95 89.08 90.53 90.10 89.67 90.56 91.00 92.46
Pendapatan operasi -1,071 -973 -505 -589 -575 -297 -339 -227 -137 -21 290 526 680 887 776 872 935 851 830 641
Perubahan (%) -9.19 -48.10 16.68 -2.38 -48.29 13.96 -32.96 -39.67 -84.86 -1,496.63 81.45 29.30 30.35 -12.45 12.38 7.14 -8.94 -2.54 -22.72
% daripada Hasil -22.86 -22.01 -11.22 -13.92 -13.00 -5.94 -6.06 -3.80 -2.16 -0.33 4.35 7.33 9.05 10.92 9.47 9.90 10.33 9.44 9.00 7.54
Perbelanjaan Faedah -310 -402 -513 -486 -452 -394 -320 -290 -283 -292 -322 -299 -245 -204 -164 -143 -138 -141 -145 -143
Perubahan (%) 29.85 27.60 -5.27 -7.07 -12.73 -18.83 -9.49 -2.32 3.18 10.36 -7.12 -18.10 -16.87 -19.74 -12.52 -3.32 1.83 3.23 -1.66
% daripada Hasil -6.61 -9.10 -11.41 -11.49 -10.22 -7.87 -5.72 -4.84 -4.45 -4.60 -4.84 -4.17 -3.26 -2.51 -2.00 -1.62 -1.53 -1.56 -1.58 -1.68
Pendapatan bersih -1,136 -1,307 -1,165 -1,248 -510 -201 -20 139 -409 -194 463 707 959 1,178 922 1,121 1,195 1,109 997 852
Perubahan (%) 14.99 -10.82 7.07 -59.16 -60.57 -90.29 -814.39 -393.12 -52.50 -338.66 52.72 35.62 22.77 -21.75 21.64 6.63 -7.24 -10.13 -14.49
% daripada Hasil -24.24 -29.56 -25.89 -29.48 -11.52 -4.01 -0.35 2.33 -6.43 -3.06 6.96 9.85 12.77 14.50 11.25 12.73 13.21 12.30 10.81 10.02

Source: Capital IQ

Other Listings
IN:524372
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista